Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014 (2014), Article ID 482352, 12 pages
http://dx.doi.org/10.1155/2014/482352
Research Article

Dynamics of Acute Local Inflammatory Response after Autologous Transplantation of Muscle-Derived Cells into the Skeletal Muscle

1Department of Immunology, Transplant Medicine and Internal Diseases, Transplantation Institute, Medical University of Warsaw, Nowogrodzka 59, 02-006 Warsaw, Poland
2Department of Dermatology and Immunodermatology, Medical University of Warsaw, Koszykowa 82A, 02-008 Warsaw, Poland
3Department of Immunology, Center of Biostructure Research, Medical University of Warsaw, Banacha 1A, 02-097 Warsaw, Poland
4Department of Large Animal Diseases with Clinic, Warsaw University of Life Sciences (SGGW), Nowoursynowska 100, 02-797 Warsaw, Poland

Received 14 February 2014; Revised 10 July 2014; Accepted 24 July 2014; Published 27 August 2014

Academic Editor: Arkadiusz Orzechowski

Copyright © 2014 Anna Burdzinska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. A. Partridge, M. Grounds, and J. C. Sloper, “Evidence of fusion between host and donor myoblasts in skeletal muscle grafts,” Nature, vol. 273, no. 5660, pp. 306–308, 1978. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Dellavalle, M. Sampaolesi, R. Tonlorenzi et al., “Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells,” Nature Cell Biology, vol. 9, no. 3, pp. 255–267, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Fan, M. Maley, M. Beilharz, and M. Grounds, “Rapid death of injected myoblasts in myoblast transfer therapy,” Muscle and Nerve, vol. 19, no. 7, pp. 853–860, 1996. View at Google Scholar
  4. J. Huard, T. Yokoyama, R. Pruchnic et al., “Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction,” Gene Therapy, vol. 9, no. 23, pp. 1617–1626, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Suzuki, B. Murtuza, J. R. Beauchamp et al., “Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart,” The FASEB Journal, vol. 18, no. 10, pp. 1153–1155, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Guo, H. K. Haider, W. S. N. Shim et al., “Myoblast-based cardiac repair: xenomyoblast versus allomyoblast transplantation,” Journal of Thoracic and Cardiovascular Surgery, vol. 134, no. 5, pp. 1332.e2–1339.e2, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Holzer, S. Hogendoorn, L. Zürcher et al., “Autologous transplantation of porcine myogenic precursor cells in skeletal muscle,” Neuromuscular Disorders, vol. 15, no. 3, pp. 237–244, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. X. Xu, Z. Yang, Q. Liu, and Y. Wang, “In vivo fluorescence imaging of muscle cell regeneration by transplanted EGFP-labeled myoblasts,” Molecular Therapy, vol. 18, no. 4, pp. 835–842, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Bencze, E. Negroni, D. Vallese et al., “Proinflammatory macrophages enhance the regenerative capacity of human myoblasts by modifying their kinetics of proliferation and differentiation,” Molecular Therapy, vol. 20, no. 11, pp. 2168–2179, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. K. L. Pellegrini and M. W. Beilharz, “The survival of myoblasts after intramuscular transplantation is improved when fewer cells are injected,” Transplantation, vol. 91, no. 5, pp. 522–526, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Skuk, M. Paradis, M. Goulet, and J. P. Tremblay, “Ischemic central necrosis in pockets of transplanted myoblasts in nonhuman primates: implications for cell-transplantation strategies,” Transplantation, vol. 84, no. 10, pp. 1307–1315, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Bouchentouf, B. F. Benabdallah, P. Bigey, T. M. Yau, D. Scherman, and J. P. Tremblay, “Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles,” Gene Therapy, vol. 15, no. 6, pp. 404–414, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Bouchentouf, B. F. Benabdallah, J. Rousseau, L. M. Schwartz, and J. P. Tremblay, “Induction of anoikis following myoblast transplantation into SCID mouse muscles requires the Bit1 and FADD pathways,” American Journal of Transplantation, vol. 7, no. 6, pp. 1491–1505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Suzuki, B. Murtuza, J. R. Beauchamp et al., “Role of interleukin-1β in acute inflammation and graft death after cell transplantation to the heart,” Circulation, vol. 110, no. 11, pp. II219–II224, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. L. M. Sammels, E. Bosio, C. T. Fragall, M. D. Grounds, N. Van Rooijen, and M. W. Beilharz, “Innate inflammatory cells are not responsible for early death of donor myoblasts after myoblast transfer therapy,” Transplantation, vol. 77, no. 12, pp. 1790–1797, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. S. I. Hodgetts, M. W. Beilharz, A. A. Scalzo, and M. D. Grounds, “Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or NK1.1+ cells,” Cell Transplantation, vol. 9, no. 4, pp. 489–502, 2000. View at Google Scholar · View at Scopus
  17. D. Skuk, N. Caron, M. Goulet, B. Roy, F. Espinosa, and J. P. Tremblay, “Dynamics of the early immune cellular reactions after myogenic cell transplantation,” Cell Transplantation, vol. 11, no. 7, pp. 671–681, 2002. View at Google Scholar · View at Scopus
  18. U. Bartoszuk-Bruzzone, A. Burdziń, A. Orzechowski, and Z. Kłos, “Protective effect of sodium ascorbate on efficacy of intramuscular transplantation of autologous muscle derived cells,” Muscle and Nerve, vol. 45, no. 1, pp. 32–38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Burdzińska, U. Bartoszuk-Bruzzone, M. M. Godlewski, and A. Orzechowski, “Sodium ascorbate and basic fibroblast growth factor protect muscle-derived cells from H2O2-induced oxidative stress,” Comparative Medicine, vol. 56, no. 6, pp. 493–501, 2006. View at Google Scholar · View at Scopus
  20. Z. Qu, L. Balkir, J. C. T. van Deutekom, P. D. Robbins, R. Pruchnic, and J. Huard, “Development of approaches to improve cell survival in myoblast transfer therapy,” Journal of Cell Biology, vol. 142, no. 5, pp. 1257–1267, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Pawlikowska, B. Gajkowska, J. Hocquette, and A. Orzechowski, “Not only insulin stimulates mitochondriogenesis in muscle cells, but mitochondria are also essential for insulin-mediated myogenesis,” Cell Proliferation, vol. 39, no. 2, pp. 127–145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Imanishi, A. Saito, H. Komoda et al., “Allogenic mesenchymal stem cell transplantation has a therapeutic effect in acute myocardial infarction in rats,” The Journal of Molecular and Cellular Cardiology, vol. 44, no. 4, pp. 662–671, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Gala, A. Burdzinska, M. Idziak, E. Wilczek, and L. Paczek, “Transplantation of mesenchymal stem cells into the skeletal muscle induces cytokine generation,” Cytokine, vol. 64, pp. 243–250, 2013. View at Google Scholar
  24. K. Fischer, R. Andreesen, and A. Mackensen, “An improved flow cytometric assay for the determination of cytotoxic T lymphocyte activity,” The Journal of Immunological Methods, vol. 259, no. 1-2, pp. 159–169, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Burdzińska, R. Crayton, B. Dybowski et al., “The effect of endoscopic administration of autologous porcine muscle-derived cells into the urethral sphincter,” Urology, vol. 82, no. 3, pp. 743.e1–743.e8, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. K. L. Urish, J. B. Vella, M. Okada et al., “Antioxidant levels represent a major determinant in the regenerative capacity of muscle stem cells,” Molecular Biology of the Cell, vol. 20, no. 1, pp. 509–520, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Lescaudron, E. Peltékian, J. Fontaine-Pérus et al., “Blood borne macrophages are essential for the triggering of muscle regeneration following muscle transplant,” Neuromuscular Disorders, vol. 9, no. 2, pp. 72–80, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. J. G. Tidball and M. Wehling-Henricks, “Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo,” The Journal of Physiology, vol. 578, no. 1, pp. 327–336, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. P. F. Lesault, M. Theret, M. Magnan et al., “Macrophages Improve Survival, Proliferation and Migration of Engrafted Myogenic Precursor Cells into MDX Skeletal Muscle,” PLoS ONE, vol. 7, no. 10, Article ID e46698, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Ito, J. T. Vilquin, D. Skuk et al., “Myoblast transplantation in non-dystrophic dog,” Neuromuscular Disorders, vol. 8, no. 2, pp. 95–110, 1998. View at Publisher · View at Google Scholar · View at Scopus